Assessing the intestinal microbiota in the SHINE Trial

Clinical Infectious Diseases

Volumn 61, Issue , 2015, Pages S738-S744

  Gough, Ethan K ^a   Prendergast, Andrew J ^b,c   Mutasa, Kuda E ^b   Stoltzfus, Rebecca J ^d   Manges, Amee R ^e  

^a MCGILL UNIVERSITY   (Canada)

^b Zvitambo Institute for Maternal and Child Health Research   (Zimbabwe)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d Cornell University ^*  (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

environmental enteric dysfunction; infant; microbiota; stunting

Indexed keywords

CHILD GROWTH; DIARRHEA; DIET THERAPY; DNA SEQUENCE; ENVIRONMENTAL ENTERIC DYSFUNCTION; GASTROINTESTINAL DISEASE; HUMAN; HYGIENE; INFANT FEEDING; INTESTINE FLORA; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SANITATION; STUNTING; ZIMBABWE; CONTROLLED STUDY; DIET; FEMALE; GENETICS; GROWTH DISORDER; INFANT; INFANT NUTRITION; INTESTINE; MALE; METHODOLOGY; MICROBIOLOGY; MOLECULAR TYPING; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RURAL POPULATION;

DIET; FEMALE; GASTROINTESTINAL MICROBIOME; GROWTH DISORDERS; HUMANS; INFANT; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INTESTINES; MALE; MOLECULAR TYPING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RURAL POPULATION; SEQUENCE ANALYSIS, DNA; ZIMBABWE;

EID: 84950322331     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ850     Document Type: Review

References (79)

1. The Sanitation Hygiene Infant Nutrition Efficacy (SHINE) Trial Team. The Sanitation Hygiene Infant Nutrition Efficacy (SHINE) trial: Rationale, design and methods. Clin Infect Dis 2015; 61(suppl 7): S685-702.
2. Dibner JJ, Richards JD. Antibiotic growth promoters in agriculture: History and mode of action. Poult Sci 2005; 84:634-43.
3. Gough EK, Moodie EEM, Prendergast AJ, et al. The impact of antibiotics on growth in children in low and middle income countries: Systematic review and meta-analysis of randomised controlled trials. BMJ 2014; 348:g2267.
4. Saari A, Virta LJ, Sankilampi U, Dunkel L, Saxen H. Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life. Pediatrics 2015; 135:617-26.
5. Steenhout PG, Rochat F, Hager C. The effect of Bifidobacterium lactis on the growth of infants: A pooled analysis of randomized controlled studies. Ann Nutr Metab 2009; 55:334-40.
6. Rao S, Srinivasjois R, Patole S. Prebiotic supplementation in full-term neonates: A systematic review of randomized controlled trials. Arch Pediatr Adolesc Med 2009; 163:755-64.
7. Sjögren K, Engdahl C, Henning P, et al. The gut microbiota regulates bone mass in mice. J Bone Miner Res 2012; 27:1357-67.
8. Cho I, Yamanishi S, Cox L, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 2012; 488:621-6.
9. Sullivan A, Edlund C, Nord CE. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 2001; 1:101-14.
10. Rafii F, Sutherland JB, Cerniglia CE. Effects of treatment with antimicrobial agents on the human colonic microflora. Ther Clin Risk Manag 2008; 4:1343-58.
11. Gerber GK, Onderdonk AB, Bry L. Inferring dynamic signatures of microbes in complex host ecosystems. PLoS Comput Biol 2012; 8: E1002624.
12. Hathaway MR, Dayton WR, White ME, Henderson TL, Henningson TB. Serum insulin-like growth factor I (IGF-I) concentrations are increased in pigs fed antimicrobials. J Anim Sci 1996; 74:1541-7.
13. Hathaway MR, Dayton WR, White ME, Henderson TL, Young DA, Doan TN. Effect of feed intake on antimicrobially induced increases in porcine serum insulin-like growth factor I. J Anim Sci 1999; 77:3208-14.
14. Hathaway MR, Dayton WR, White ME, Pampusch MS. Effects of antimicrobials and weaning on porcine serum insulin-like growth factor binding protein levels. J Anim Sci 2003; 81:1456-63.
15. Monira S, Nakamura S, Gotoh K, et al. Gut microbiota of healthy and malnourished children in Bangladesh. Front Microbiol 2011; 2:228.
16. Gupta SS, Mohammed MH, Ghosh TS, Kanungo S, Nair GB, Mande SS. Metagenome of the gut of a malnourished child. Gut Pathog 2011; 3:7.
17. Ghosh TS, Sen Gupta S, Bhattacharya T, et al. Gut microbiomes of Indian children of varying nutritional status. PLoS One 2014; 9:e95547.
18. Subramanian S, Huq S, Yatsunenko T, et al. Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature 2014; 510:417-21.
19. Smith MI, Yatsunenko T, Manary MJ, et al. Gut microbiomes of Malawian twin pairs discordant for Kwashiorkor. Science 2013; 339:548-54.
20. Ridaura VK, Faith JJ, Rey FE, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013; 341: 1241214.
21. De Vries LE, Valles Y, Agerso Y, et al. The gut as reservoir of antibiotic resistance: Microbial diversity of tetracycline resistance in mother and infant. PLoS One 2011; 6:e21644.
22. Vaishampayan PA, Kuehl JV, Froula JL, Morgan JL, Ochman H, Francino MP. Comparative metagenomics and population dynamics of the gut microbiota in mother and infant. Genome Biol Evol 2010; 6:53-66.
23. Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 2010; 107:11971-75.
24. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol 2007; 5:e177.
25. Koenig JE, Spor A, Scalfone N, et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A 2011; 108:4578-85.
26. Avershina E, Storro O, Oien T, et al. Bifidobacterial succession and correlation networks in a large unselected cohort of mothers and their children. Appl Environ Microbiol 2013; 79:497-507.
27. Turroni F, Peano C, Pass DA, et al. Diversity of Bifidobacteria within the infant gut microbiota. PLoS One 2012; 7:e36957.
28. Prendergast AJ, Rukobo S, Chasekwa B, et al. Stunting is characterized by chronic inflammation in Zimbabwean infants. PLoS One 2014; 9.
29. Kosek M, Haque R, Lima A, et al. Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants. Am J Trop Med Hyg 2013; 88:390-6.
30. Lin A, Arnold BF, Afreen S, et al. Household environmental conditions are associated with enteropathy and impaired growth in rural Bangladesh. Am J Trop Med Hyg 2013; 89:130-7.
31. Weisz AJ, Manary MJ, Stephenson K, et al. Abnormal gut integrity is associated with reduced linear growth in rural Malawian children. J Pediatr Gastroenterol Nutr 2012; 55:747-50.
32. Goto R, Mascie-Taylor CGN, Lunn PG. Impact of intestinal permeability, inflammation status and parasitic infections on infant growth faltering in rural Bangladesh. Br J Nutr 2009; 101:1509-16.
33. Campbell DI, Elia M, Lunn PG. Growth faltering in rural Gambian infants is associated with impaired small intestinal barrier function, leading to endotoxemia and systemic inflammation. J Nutr 2003; 133: 1332-8.
34. Campbell DI, McPhail G, Lunn PG, Elia M, Jeffries DJ. Intestinal inflammation measured by fecal neopterin in Gambian children with enteropathy: Association with growth failure, Giardia lamblia, and intestinal permeability. J Pediatr Gastroenterol Nutr 2004; 39:153-7.
35. Lang D; MAL-ED Network Investigators. Opportunities to assess factors contributing to the development of the intestinal microbiota in infants living in developing countries. Microb Ecol Health Dis 2015; 26:28316.
36. Taniuchi M, Sobuz SU, Begum S, et al. Etiology of diarrhea in Bangladeshi infants in the first year of life analyzed using molecular methods. J Infect Dis 2013; 208:1794-802.
37. Ngure FM, Humphrey JH, Mbuya MNN, et al. Formative research on hygiene behaviors and geophagy among infants and young children and implications of exposure to fecal bacteria. Am J Trop Med Hyg 2013; 89:709-16.
38. Gaboriau-Routhiau V, Rakotobe S, Lecuyer E, et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009; 31:677-89.
39. Piccirillo CA. Regulatory T cells in health and disease. Cytokine 2008; 43:395-401.
40. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 2004; 118:229-41.
41. Rakoff-Nahoum S, Hao L, Medzhitov R. Role of Toll-like receptors in spontaneous commensal-dependent colitis. Immunity 2006; 25:319-29.
42. Slack E, Hapfelmeier S, Stecher B, et al. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 2009; 325:617-20.
43. Vaarala O, Atkinson MA, Neu J. The 'perfect storm' for type 1 diabetes: The complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 2008; 57:2555-62.
44. Troy EB, Kasper DL. Beneficial effects of Bacteroides fragilis polysaccharides on the immune system. Front Biosci 2010; 1:25-34.
45. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005; 122:107-18.
46. Ballal SA, Gallini CA, Segata N, Huttenhower C, Garrett WS. Host and gut microbiota symbiotic factors: Lessons from inflammatory bowel disease and successful symbionts. Cell Microbiol 2011; 13:508-17.
47. Karczewski J, Troost FJ, Konings I, et al. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol 2010; 298:G851-9.
48. Liu Z, Shen T, Zhang P, Ma Y, Qin H. Lactobacillus plantarum surface layer adhesive protein protects intestinal epithelial cells against tight junction injury induced by enteropathogenic Escherichia coli. Mol Biol Rep 2011; 38:3471-80.
49. Spinler JK, Taweechotipatr M, Rognerud CL, Ou CN, Tumwasorn S, Versalovic J. Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe 2008; 14:166-71.
50. Moore AM, Munck C, Sommer MO, Dantas G. Functional metagenomic investigations of the human intestinal microbiota. Front Microbiol 2011; 2:1-8.
51. Musso G, Gambino R, Cassader M. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med 2011; 62:361-80.
52. Pryde SE, Duncan SH, Hold GL, Stewart CS, Flint HJ. The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 2002; 217:133-9.
53. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444:1027-131.
54. Walker AW, Duncan SH, McWilliam Leitch EC, Child MW, Flint HJ. pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl Environ Microbiol 2005; 71:3692-700.
55. Kelly P, Menzies I, Crane R, et al. Responses of small intestinal architecture and function over time to environmental factors in a tropical population. Am J Trop Med Hyg 2004; 70:412-9.
56. Gough EK, Stephens DA, Moodie EE, et al. Linear growth faltering in infants is associated with Acidaminococcus sp. and community-level changes in the gut microbiota. Microbiome 2015; 3:24.
57. Pop M, Walker AW, Paulson J, et al. Diarrhea in young children from low-income countries leads to large-scale alterations in intestinal microbiota composition. Genome Biol 2014; 15:R76.
58. Eggesbo M, Moen B, Peddada S, et al. Development of gut microbiota in infants not exposed to medical interventions. APMIS 2011; 119:17-35.
59. Prentice AM, Gershwin ME, Schaible UE, Keusch GT, Victora CG, Gordon JI. New challenges in studying nutrition-disease interactions in the developing world. J Clin Invest 2008; 118:1322-9.
60. Bode L. Recent advances on structure, metabolism, and function of human milk oligosaccharides. J Nutr 2006; 136:2127-30.
61. Newburg DS. Oligosaccharides in human milk and bacterial colonization. J Pediatr Gastroenterol Nutr 2000; 30:S8-17.
62. Newburg DS, Ruiz-Palacios GM, Morrow AL. Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr 2005; 25:37-58.
63. Zivkovic AM, German JB, Lebrilla CB, Mills DA. Human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proc Natl Acad Sci U S A 2011; 108:4653-8.
64. Kurokawa K, Itoh T, Kuwahara T, et al. Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res 2007; 14:169-81.
65. De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 2010; 107:14691-6.
66. Adu-Afarwuah S, Lartey A, Brown KH, Zlotkin S, Briend A, Dewey KG. Randomized comparison of 3 types of micronutrient supplements for home fortification of complementary foods in Ghana: Effects on growth and motor development. Am J Clin Nutr 2007; 86:412-20.
67. Prendergast AJ, Humphrey JH, Mutasa K, et al. Assessment of environmental enteric dysfunction in the SHINE trial: Methods and challenges. Clin Infect Dis 2015; 61(suppl 7):S726-32.
68. Church JA, Fitzgerald F, Walker AS, Gibb DM, Prendergast AJ. The expanding role of co-trimoxazole in developing countries. Lancet Infect Dis 2015; 15:327-39.
69. Iliff PJ, Piwoz EG, Tavengwa NV, et al. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS 2005; 19:699-708.
70. Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011; 12:R60.
71. Abubucker S, Segata N, Goll J, et al. Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput Biol 2012; 8:e1002358.
72. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59-65.
73. Tibshirani R. Regression shrinkage and selection via the LASSO. J R Stat Soc Ser B 1996; 58:267-88.
74. Breiman L. Random forests. Eur J Math 2001; 45:5-32.
75. Strimmer K. fdrtool: A versatile R package for estimating local and tail area-based false discovery rates. Bioinformatics 2008; 24:1461-2.
76. De Onis M, Garza C, Victora CG, Onyango AW, Frongillo EA, Martines J. The WHO Multicentre Growth Reference Study: Planning, study design, and methodology. Food Nutr Bull 2004; 25:S15-26.
77. Daniel RM, Cousens SN, De Stavola BL, Kenward MG, Sterne JAC. Methods for dealing with time-dependent confounding. Stat Med 2013; 32:1584-618.
78. Platt RW, Schisterman EF, Cole SR. Time-modified confounding. Am J Epidemiol 2009; 170:687-94.
79. VanderWeele TJ. Marginal structural models for the estimation of direct and indirect effects. Epidemiology 2009; 20:18-26.